All About SCA1

SCA1 or Spinocerebellar Ataxia 1 is a rare neuromuscular disease. The National Ataxia Foundation is proud to host this webinar presented by Dr. Sharan Srinivasan on May 4th, 2023. In "All About SCA1", he gave an overview of the causes and symptoms of the disease, the typical diagnostic journey for those affected, and what to expect for clinical care.

For more information on SCA1, register for our next webinar on Research and Treatment Development for SCA1 on May 18th at 12 pm CDT: https://us02web.zoom.us/webinar/regis...

For more information on Ataxia, please visit our website: https://www.ataxia.org

Become a Free NAF member! https://bit.ly/JoinNAF

Follow us on Social Media!
NAF Facebook:   / ataxiafounda.  .
NAF Twitter:   / naf_ataxia  
NAF Instagram:   / ataxiafound.  .
Ataxia Subreddit:   / ataxia  

About the Speaker:

Sharan Srinivasan, MD, PhD is currently a Clinical Instructor in the Department of Neurology, Movement Disorders Division, at the University of Michigan. He obtained his bachelor’s degree from Northwestern University and his MD and PhD degrees from the University of Michigan, where he also finished his residency in general neurology. He completed a movement disorders fellowship focused in Ataxia at Mass General Brigham/Harvard before returning to the University of Michigan. Clinically, Dr. Srinivasan is dedicated to the care of ataxia patients, with a focus on hereditary degenerative diseases. He also has a dedicated research program discovering and developing novel therapeutics for Spinocerebellar Ataxias (SCAs) and other related cerebellar disorders.

About the Series:

NAF is producing a series of monthly educational webinars that focus on one type of Ataxia at a time. Each month we will feature a different type. Clinical experts will join us to take a look at the causes and symptoms of the disease, the typical diagnostic journey for those affected, and what to expect for clinical care. Research experts will teach us how the disease is studied and give an overview of the current state of research and drug development.